Just as an FYI, I have been doing some digging into the Arthropharm oral OA trial (using Elmiron)...
They quote the following with regard to concerns anyone has with regard to Elmiron and retinal problems - “Very long-term continuous daily dosing (greater than 7 years, over 1.5 kg PPS accumulated dose) has been linked with a degenerative maculopathy in 20% of patients with interstitial cystitis, however the causative mechanism is yet to be established.”
- Forums
- ASX - By Stock
- PAR. SP
Just as an FYI, I have been doing some digging into the...
Featured News
Add PAR (ASX) to my watchlist
(20min delay)
|
|||||
Last
25.5¢ |
Change
0.000(0.00%) |
Mkt cap ! $83.95M |
Open | High | Low | Value | Volume |
25.5¢ | 25.5¢ | 24.0¢ | $43.44K | 174.4K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
2 | 9752 | 25.0¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
24.0¢ | 5675 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
2 | 10858 | 0.250 |
4 | 34735 | 0.245 |
6 | 97212 | 0.240 |
7 | 93556 | 0.235 |
6 | 198067 | 0.230 |
Price($) | Vol. | No. |
---|---|---|
0.255 | 45146 | 11 |
0.260 | 2500 | 1 |
0.265 | 5084 | 2 |
0.270 | 21800 | 3 |
0.275 | 15436 | 3 |
Last trade - 15.59pm 28/08/2024 (20 minute delay) ? |
Featured News
PAR (ASX) Chart |
The Watchlist
UNT
UNITH LTD
Idan Schmorak, CEO
Idan Schmorak
CEO
Previous Video
Next Video
SPONSORED BY The Market Online